# Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients

> **NCT01320358** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 30 (estimated)

## Conditions studied

- Detection Accuracy
- Patient Compliance

## Interventions

- **DRUG:** ECMPS-IEM

## Key facts

- **NCT ID:** NCT01320358
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-10
- **Primary completion:** 2011-11-18
- **Final completion:** 2011-11-18
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-02-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01320358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01320358, "Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01320358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*